Chargement en cours...
USP18 downregulation in peripheral blood mononuclear cells predicts nonresponse to interferon-based triple therapy in patients with chronic hepatitis C, genotype 1: a pilot study
BACKGROUND AND AIMS: Patients with advanced liver fibrosis owing to chronic hepatitis C virus genotype 1 represent a difficult-to-treat group even if a protease inhibitor is added to pegylated interferon alpha and ribavirin. Therefore, only patients with a high chance of cure should be treated with...
Enregistré dans:
| Publié dans: | Ther Clin Risk Manag |
|---|---|
| Auteurs principaux: | , , , , , , , |
| Format: | Artigo |
| Langue: | Inglês |
| Publié: |
Dove Medical Press
2015
|
| Sujets: | |
| Accès en ligne: | https://ncbi.nlm.nih.gov/pmc/articles/PMC4687952/ https://ncbi.nlm.nih.gov/pubmed/26719699 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.2147/TCRM.S94010 |
| Tags: |
Ajouter un tag
Pas de tags, Soyez le premier à ajouter un tag!
|